Gates Foundation Strategic Investment Fund Logo

Exscientia AI Limited

Exscientia plc is an artificial intelligence-driven pharmaceutical company focused on discovering, designing, and developing drugs in a fast, efficient manner, with three AI-designed drugs that are in Phase 1 human clinical trials. The foundation invested in the Company to develop Read More


Atreca is a biotechnology company that employs its proprietary discovery platform to generate and develop therapeutics based on its ability to rapidly characterize the human adaptive immune response at the single cell level.  The Atreca platform enables the high-throughput phylogenetic Read More


Visterra is a biotechnology company that uses its proprietary platform to identify unique disease targets and design and engineer effective biological therapeutics.

Sera Prognostics

Sera Prognostics, based in Salt Lake City, UT, is developing innovative diagnostic tests designed for the early prediction of preterm birth risk and other pregnancy complications.

Lodo Therapeutics

Lodo Therapeutics is creating a best-in-class natural product drug discovery platform for the discovery, biosynthesis, and characterization of new, genetically encoded small molecules.


Kymab has developed a proprietary mouse platform which contains the full range of human antibodies, leading to faster discovery of prophylactic and therapeutic monoclonal antibodies.